Login
Super Investors VANGUARD LONG-TERM CORPORATE BOND INDEX FUND

VANGUARD LONG-TERM CORPORATE BOND INDEX FUND

Vanguard Scottsdale Funds · net assets $9.22B · 2780 holdings as of May 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

DBT: 99.3% · STIV: 0.8% · DIR: 0.0% · DCR: 0.0%

Financial position

Total assets
$9.26B
Total liabilities
$36.3M
Net assets
$9.22B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $2.07B $2.08B $3.33B
Reinvestment $2.84M $3.38M $3.12M
Redemptions $2.25B $1.76B $2.73B
Net realized gain (non-derivative) $-60.1M $-30.4M $-48.6M
Net unrealized appreciation (non-derivative) $-257M $22.7M $150M

The three months of the reporting period, as filed; month 3 ends May 31, 2026.

Credit spread risk (change in value per 1bp spread move)

Tenor Investment grade Non-investment grade
3 months $-10.3K $-194
1 year $-210K $-3.92K
5 years $-860K $-15.3K
10 years $-5.36M $-79.4K
30 years $-4.67M $-59.7K

Filing details

Registrant
Vanguard Scottsdale Funds
Registrant CIK
1021882
Registrant LEI
549300Y88GQ3VLJIBX57
Series
VANGUARD LONG-TERM CORPORATE BOND INDEX FUND
Series ID
S000026864
Series LEI
ZIWMTR5KXH6IQX7B0013
SEC file number
811-07803
Address
100 Vanguard Boulevard, Malvern, US-PA, 19355, US
Phone
610-669-1000
Form
NPORT-P
Filed
July 29, 2026
Report period ends
August 31, 2026
Report month ends
May 31, 2026
Accession number
000102188226000639
Holding Value % of net assets
Vanguard Cmt Funds-vanguard Market Liquidity Fund STIV $68.6M 0.74%
Anheuser-busch Cos LLC / Anheuser-busch Inbev Worldwide Inc DBT $34.2M 0.37%
Cvs Health Corp DBT $30.7M 0.33%
Meta Platforms Inc DBT $26.3M 0.28%
Boeing Co/the DBT $24.6M 0.27%
Pfizer Investment Enterprises Pte Ltd DBT $24.4M 0.27%
Amazon.com Inc DBT $23.5M 0.26%
Oracle Corp DBT $21.9M 0.24%
AT&T Inc DBT $21.5M 0.23%
AT&T Inc DBT $21.1M 0.23%
Cvs Health Corp DBT $20.9M 0.23%
Bank Of America Corp DBT $20.1M 0.22%
Goldman Sachs Group Inc/the DBT $19.2M 0.21%
Meta Platforms Inc DBT $19M 0.21%
Meta Platforms Inc DBT $18.3M 0.20%
Alphabet Inc DBT $18.1M 0.20%
AT&T Inc DBT $18.1M 0.20%
AT&T Inc DBT $17.5M 0.19%
Bank Of America Corp DBT $17.3M 0.19%
Abbvie Inc DBT $17.1M 0.19%
Boeing Co/the DBT $16.8M 0.18%
Comcast Corp DBT $16.6M 0.18%
Alphabet Inc DBT $16M 0.17%
Apple Inc DBT $15.8M 0.17%
Microsoft Corp DBT $15.7M 0.17%
Verizon Communications Inc DBT $15.6M 0.17%
Boeing Co/the DBT $15.3M 0.17%
Microsoft Corp DBT $15.2M 0.16%
Amgen Inc DBT $15.2M 0.16%
Goldman Sachs Group Inc/the DBT $15.1M 0.16%
Oracle Corp DBT $15M 0.16%
Pfizer Inc DBT $14.9M 0.16%
Goldman Sachs Group Inc/the DBT $14.7M 0.16%
Abbvie Inc DBT $14.6M 0.16%
Pfizer Investment Enterprises Pte Ltd DBT $14.5M 0.16%
Visa Inc DBT $14.5M 0.16%
Boeing Co/the DBT $14.5M 0.16%
Morgan Stanley DBT $14.4M 0.16%
Pfizer Investment Enterprises Pte Ltd DBT $14.4M 0.16%
Meta Platforms Inc DBT $14.4M 0.16%
Rtx Corp DBT $14.4M 0.16%
Jpmorgan Chase & Co DBT $14.3M 0.16%
Abbott Laboratories DBT $14.3M 0.15%
Cvs Health Corp DBT $14.2M 0.15%
Wells Fargo & Co DBT $13.9M 0.15%
Unitedhealth Group Inc DBT $13.9M 0.15%
Oracle Corp DBT $13.8M 0.15%
Alphabet Inc DBT $13.8M 0.15%
Goldman Sachs Group Inc/the DBT $13.8M 0.15%
Pacific Gas And Electric Co DBT $13.6M 0.15%
Wells Fargo & Co DBT $13.6M 0.15%
Bristol-myers Squibb Co DBT $13.6M 0.15%
Cigna Group/the DBT $13.4M 0.15%
Amazon.com Inc DBT $13.4M 0.14%
Abbott Laboratories DBT $13.1M 0.14%
Wells Fargo & Co DBT $13.1M 0.14%
Meta Platforms Inc DBT $13M 0.14%
Glaxosmithkline Capital Inc DBT $13M 0.14%
Abbvie Inc DBT $12.8M 0.14%
Broadcom Inc DBT $12.7M 0.14%

Showing top 60 of 2780 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support